GP0146A Breast Cancer US

Global Patients is currently looking for women 18 years old and over, diagnosed with Hormone Receptor positive HR+ (i.e., Estrogen Receptor-Positive, ER+)/HER2 negative breast cancer to participate in an upcoming paid interview study. The purpose of this study is to learn about your experience with HR+ (i.e., ER+)/HER2 negative breast cancer including disease symptoms and treatment side-effects, and their impact on your quality of life, activities of daily living, and functioning.

Study participants, who agree to provide evidence of diagnosis, will be invited to attend a telephone interview that will last approximately 90 minutes in total. There is no medical treatment being provided as part of this study and all participants will be compensated for their time.

If you or a loved one has been diagnosed with HR+ (i.e., ER+)/HER2 negative breast cancer and are interested in participating or would like more information about the study, please contact

Join this Study
Are you already a member of Global Patients?